Document Detail


Pharmacotherapy of prostatitis.
MedLine Citation:
PMID:  20569089     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
IMPORTANCE OF THE FIELD: Prostatitis is a prevalent and morbid condition with a significant impact on a patient's quality of life. The four distinct prostatitis syndromes have different pathophysiologies, therapy and prognosis. Acute and chronic bacterial prostatitis is best treated with appropriate antibiotics that penetrate the prostate and kill the causative organisms. The most challenging category to treat is category III or chronic prostatitis/chronic pelvic pain syndrome.
AREAS COVERED IN THE REVIEW: This review covers the categories of prostatitis and currently recommended therapies, as well as novel approaches on the horizon.
WHAT THE READER WILL GAIN: Knowledge of the current framework for the diagnosis and management of the diverse prostatitis spectrum.
TAKE HOME MESSAGE: Prostatitis is a diverse group of syndromes. Chronic prostatitis/chronic pelvic pain syndrome is a multifactorial syndrome that requires a multimodal approach to effectively treat the patient. The UPOINT technique is used to clinically phenotype these patients and drive the selection of multimodal therapy.
Authors:
Devon C Snow; Daniel A Shoskes
Related Documents :
11346319 - Chronic fatigue: symptom and syndrome.
7650209 - Human herpesvirus 6 and human herpesvirus 7 in chronic fatigue syndrome.
11560809 - Muscle pain due to injury.
20456159 - Persistent post-traumatic headache, postconcussion syndrome, and whiplash injuries: the...
8860799 - Evidence that abnormalities of central neurohormonal systems are key to understanding f...
3658839 - The yellow nail syndrome in an 8-year-old girl.
9638839 - Polyostotic fibrous dysplasia associated with intramuscular myxomas: mazabraud's syndrome.
22246419 - Different clinical presentation of the hyperimmunoglobulin d syndrome (hids) (four case...
6712399 - Hemolytic uremic syndrome after campylobacter-induced diarrhea in an adult.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Expert opinion on pharmacotherapy     Volume:  11     ISSN:  1744-7666     ISO Abbreviation:  Expert Opin Pharmacother     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-09-10     Completed Date:  2010-12-30     Revised Date:  2011-08-25    
Medline Journal Info:
Nlm Unique ID:  100897346     Medline TA:  Expert Opin Pharmacother     Country:  England    
Other Details:
Languages:  eng     Pagination:  2319-30     Citation Subset:  IM    
Affiliation:
Glickman Urological and Kidney Institute, Cleveland Clinic, Desk Q10-1, 9500 Euclid Ave, Cleveland, OH 44195, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
5-alpha Reductase Inhibitors / therapeutic use
Adrenergic alpha-Antagonists / therapeutic use
Anti-Bacterial Agents / therapeutic use
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Antipsychotic Agents / therapeutic use
Complementary Therapies
Humans
Male
Neuromuscular Agents / therapeutic use
Physical Therapy Modalities
Phytotherapy
Prostatitis / classification*,  drug therapy*,  therapy
Chemical
Reg. No./Substance:
0/5-alpha Reductase Inhibitors; 0/Adrenergic alpha-Antagonists; 0/Anti-Bacterial Agents; 0/Anti-Inflammatory Agents, Non-Steroidal; 0/Antipsychotic Agents; 0/Neuromuscular Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Current treatment options for tendinopathy.
Next Document:  Exemestane in postmenopausal women with early or advanced breast cancer: a review.